Evidence map›Paper›PMID 38543515›Full record

ArticleMicroorganisms2024

Epidemiology of Viral Hepatitis in the Indigenous Populations of the Arctic Zone of the Republic of Sakha (Yakutia).

Vera S Kichatova, Maria A Lopatukhina, Ilya A Potemkin, Fedor A Asadi Mobarkhan, Olga V Isaeva, Mikhail D Chanyshev, Albina G Glushenko, Kamil F Khafizov, Tatyana D Rumyantseva, Sergey I Semenov and 3 more

Open access · goldAbstract read
In one paragraph

Article in Microorganisms, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.5field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Vera S KichatovaCentral Research Institute of Epidemiology, 111123 Moscow, Russia.ORCID 0000-0002-7838-6965
Maria A LopatukhinaCentral Research Institute of Epidemiology, 111123 Moscow, Russia.
Ilya A PotemkinCentral Research Institute of Epidemiology, 111123 Moscow, Russia.ORCID 0000-0001-7559-4219
Fedor A Asadi MobarkhanCentral Research Institute of Epidemiology, 111123 Moscow, Russia.ORCID 0000-0002-1838-8037
Olga V IsaevaCentral Research Institute of Epidemiology, 111123 Moscow, Russia.
Mikhail D ChanyshevCentral Research Institute of Epidemiology, 111123 Moscow, Russia.
Albina G GlushenkoCentral Research Institute of Epidemiology, 111123 Moscow, Russia.
Kamil F KhafizovCentral Research Institute of Epidemiology, 111123 Moscow, Russia.ORCID 0000-0001-5524-0296
Tatyana D RumyantsevaScience and Research Department, Arctic State Agrotechnological University, 677008 Yakutsk, Russia.
Sergey I SemenovResearch Center, Ammosov North-Eastern Federal University, 677010 Yakutsk, Russia.ORCID 0000-0001-8099-2270
Karen K KyuregyanCentral Research Institute of Epidemiology, 111123 Moscow, Russia.ORCID 0000-0002-3599-117X
Vasiliy G AkimkinCentral Research Institute of Epidemiology, 111123 Moscow, Russia.ORCID 0000-0003-4228-9044
Mikhail I MikhailovCentral Research Institute of Epidemiology, 111123 Moscow, Russia.
Central Research Institute of Epidemiology · RURussian Medical Academy of Continuous Professional Education · RUArctic State Agrotechnological University · RUNorth-Eastern Federal University · RU

Funding

Russian Science Foundation 22-25-00549
6 · The paper itself

Abstract

The indigenous populations of the Arctic regions of Russia experience the lowest coverage of health-related services. We assessed the prevalence of hepatitis A, B, C, D and E viruses (HAV, HBV, HCV, HDV and HEV) among 367 healthy adult Native people of the Arctic zone of Yakutia. The HAV seroprevalence was above and increased with age. The anti-HEV IgM and IgG antibody detection rates were 4.1% and 2.5%, respectively. The average HBsAg detection rate was 4.6%, with no positive cases identified in participants aged under 30 years, confirming the effectiveness of the newborn vaccination program that began in 1998. Anti-HDV antibodies were detected in 29.4% of HBsAg-positive cases. The anti-HCV and HCV RNA detection rates peaked in the age cohort of 50-59 years (10.8% and 3.9%). No statistically significant gender differences in the prevalence of different viral hepatitis were observed. The time-scaled phylogenetic analysis demonstrated that all HBV genotype A and D strains isolated in this study were autochthonous and had an estimated most common recent ancestor (MCRA) age of around the 11th to 14th century. Unlike HBV, the HCV strains of subtypes 1b, 2a and 2k/1b were introduced from other regions of Russia in the 1980s and 1990s. The HCV 1b sequence analysis revealed a series of transmission events. In conclusion, these data emphasize the urgent need for expanded viral hepatitis screening and care programs in the indigenous populations of the Arctic zone of Yakutia.

Indexed as

ArcticgenotypesHepatitis A virusHepatitis B virusHepatitis C virusHepatitis delta virusHepatitis E virusindigenous peoplepublic healthseroprevalence

Identifiers

PMID38543515
PMCPMC10972206
OpenAlexW4392155573

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.